Incidence of brain metastases in patients receiving neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in HER2-positive early breast cancer (BC).

被引：0
|
作者：
Ferraro, Emanuela
Barrio, Andrea Veronica
Patil, Sujata
Robson, Mark E.
Dang, Chau T.
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12653
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Emanuela Ferraro
    Jasmeet Singh
    Sujata Patil
    Pedram Razavi
    Shanu Modi
    Sarat Chandarlapaty
    Andrea V. Barrio
    Rachna Malani
    Ingo K. Mellinghoff
    Adrienne Boire
    Hannah Y. Wen
    Edi Brogi
    Andrew D. Seidman
    Larry Norton
    Mark E. Robson
    Chau T. Dang
    [J]. npj Breast Cancer, 8
  • [2] Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Ferraro, Emanuela
    Singh, Jasmeet
    Patil, Sujata
    Razavi, Pedram
    Modi, Shanu
    Chandarlapaty, Sarat
    Barrio, Andrea, V
    Malani, Rachna
    Mellinghoff, Ingo K.
    Boire, Adrienne
    Wen, Hannah Y.
    Brogi, Edi
    Seidman, Andrew D.
    Norton, Larry
    Robson, Mark E.
    Dang, Chau T.
    [J]. NPJ BREAST CANCER, 2022, 8 (01)
  • [3] Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer.
    Ferraro, Emanuela
    Razavi, Pedram
    Chandarlapaty, Sarat
    Modi, Shanu
    Wen, Hannah Yong
    Brogi, Edi
    Norton, Larry
    Robson, Mark E.
    Dang, Chau T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Clinical implication of HER2 status change after neoadjuvant chemotherapy with Trastuzumab and Pertuzumab (HP) in patients with HER2-positive breast cancer
    Ferraro, Emanuela
    Safonov, Anton
    Wen, Hanna Y.
    Brogi, Edi
    Gonan, Mithat
    Barrio, Andrea V.
    Razavi, Pedram
    Chandarlapaty, Sarat
    Modi, Shanu
    Seidman, Andrew D.
    Norton, Larry
    Robson, Mark E.
    Dang, Chau T.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [5] Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience
    Hall, Benjamin James
    Bhojwani, Ajay Ashok
    Wong, Helen
    Law, Andrea
    Flint, Helen
    Ahmed, Eliyaz
    Innes, Helen
    Cliff, Joanne
    Malik, Zaf
    O'Hagan, Julie Elizabeth
    Hall, Allison
    Sripadam, Rajaram
    Tolan, Shaun
    Ali, Zulfiqar
    Hart, Clare
    Errington, Douglas
    Alam, Farida
    Giuliani, Rosa
    Mehta, Shaveta
    Khanduri, Sheena
    Thorp, Nicky
    Jackson, Richard
    Cicconi, Silvia
    Palmieri, Carlo
    [J]. BREAST JOURNAL, 2022, 2022
  • [6] Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
    von Minckwitz, Gunter
    Procter, Marion
    de Azambuja, Evandro
    Zardavas, Dimitrios
    Benyunes, Mark
    Viale, Giuseppe
    Suter, Thomas
    Arahmani, Amal
    Rouchet, Nathalie
    Clark, Emma
    Knott, Adam
    Lang, Istvan
    Levy, Christelle
    Yardley, Denise A.
    Bines, Jose
    Gelber, Richard D.
    Piccart, Martine
    Baselga, Jose
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (02): : 122 - 131
  • [7] Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer
    Douchet, G.
    Richard, Sandrine
    [J]. ONCOLOGIE, 2018, 20 (01) : 43 - 44
  • [8] Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer
    Abraham, Jame
    [J]. JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (03): : 84 - 86
  • [9] BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
    Dang, Chau
    Ewer, Michael S.
    Delaloge, Suzette
    Ferrero, Jean-Marc
    Colomer, Ramon
    de la Cruz-Merino, Luis
    Werner, Theresa L.
    Dadswell, Katherine
    Verrill, Mark
    Eiger, Daniel
    Sarkar, Sriparna
    de Haas, Sanne Lysbet
    Restuccia, Eleonora
    Swain, Sandra M.
    [J]. CANCERS, 2022, 14 (11)
  • [10] Real-world study of trastuzumab and pertuzumab combined with chemotherapy in neoadjuvant treatment for patients with HER2-positive breast cancer
    Ma, Xiangmin
    Zhang, Xiangmei
    Zhou, Xinping
    Ren, Xiaofei
    Ma, Xindi
    Zhang, Weifang
    Yang, Ruiling
    Song, Tao
    Liu, Yunjiang
    [J]. MEDICINE, 2022, 101 (40) : E30892
12345